Less Ads, More Data, More Tools Register for FREE

Pin to quick picksElementis Regulatory News (ELM)

Share Price Information for Elementis (ELM)

Share Price is delayed by 15 minutes
Get Live Data
156.00    -0.60 (-0.38%)
Bid:
156.40
Ask:
156.80
Spread: 0.40 (0.256%)
Market Cap: £891.97m
ELM Live PriceLast checked at - London Stock Exchange

Intraday Elementis Share Chart

Elementis - Pre-close Trading Statement

22 Jun 2016 07:00

ELEMENTIS PLC - Elementis - Pre-close Trading Statement

ELEMENTIS PLC - Elementis - Pre-close Trading Statement

PR Newswire

London, June 21

22 June 2016Elementis plc – pre-close trading updateElementis plc (ELM.L, the "Company" or the "Group"), the Global Specialty Chemicals Company, today issues a trading update ahead of its results for the half year ending 30 June 2016, which will be announced on 2 August 2016.Specialty Products has continued to make progress, in line with the Interim Management Statement issued in April. In coatings, sales of decorative products from the New Martinsville plant continue to make good progress and sales in Asia Pacific have resumed a growth trend, following the destocking and adjustment that took place in the Chinese economy in the second quarter of 2015. Sales in personal care continue to show impressive growth based on new products and geographic expansion. In oilfield, sales have remained relatively stable, following the sharp downturn experienced in the first half of 2015.In Chromium, as previously indicated, sales and contribution margins in North America for the first six months of the year are expected to be similar to the previous year. However, market conditions outside of North America continue to be challenging due to currency weakness against the US dollar, particularly in Eastern Europe. As a result, sales and margins outside of North America for the year as a whole are expected to be materially lower than the previous year. Consequently, earnings per share for the year as a whole is expected to be below the range of market expectations.Strong cash flow generation continues to be a feature of the Group's performance in 2016 and the net cash balance at the end of the year is expected to be ahead of the previous year.

ENDS

Enquiries:

Elementis+ 44 (0) 207 067 2999
Paul Waterman, Chief Executive Brian Taylorson, Finance Director
FTI Consulting
+ 44 (0) 203 727 1000
Deborah Scott
Matthew Cole
Date   Source Headline
1st Sep 20239:49 amRNSBlock listing Interim Review
1st Sep 20239:42 amRNSTotal Voting Rights
1st Aug 20239:44 amRNSTotal Voting Rights
27th Jul 20232:16 pmRNSHolding(s) in Company
27th Jul 20237:00 amRNSHalf-year Report
20th Jul 202312:58 pmRNSHolding(s) in Company
3rd Jul 202310:21 amRNSTotal Voting Rights
29th Jun 20234:29 pmRNSDirector/PDMR Shareholding
23rd Jun 20239:32 amRNSDirector/PDMR Shareholding
30th May 20238:06 amRNSDirector Declaration
2nd May 20239:37 amRNSTotal Voting Rights
26th Apr 20232:12 pmRNSResult of AGM
26th Apr 20237:00 amRNSAGM Trading Statement
17th Apr 202310:15 amRNSDirector/PDMR Shareholding
17th Apr 202310:10 amRNSDirector/PDMR Shareholding
13th Apr 20234:24 pmRNSDirector/PDMR Shareholding
3rd Apr 202311:28 amRNSDirector Declaration
3rd Apr 20239:34 amRNSTotal Voting Rights
24th Mar 20239:27 amRNSDirector/PDMR Shareholding
22nd Mar 20234:02 pmRNSAnnual Financial Report & Notice of AGM
17th Mar 20232:58 pmRNSAdditional Listing
14th Mar 20237:30 amRNSDirector Declaration
9th Mar 20232:50 pmRNSDirector/PDMR Shareholding
9th Mar 20232:47 pmRNSDirector/PDMR Shareholding
7th Mar 20237:00 amRNSPreliminary results year ended 31 December 2022
1st Mar 20239:53 amRNSBlock listing Interim Review
1st Mar 20239:39 amRNSTotal Voting Rights
31st Jan 20233:04 pmRNSSale of Chromium business
19th Jan 20237:00 amRNSTrading Update
3rd Jan 20239:47 amRNSTotal Voting Rights
8th Dec 20222:10 pmRNSDirector/PDMR Shareholding
30th Nov 20227:00 amRNSSale of Chromium business
23rd Nov 20223:54 pmRNSHolding(s) in Company
16th Nov 20221:43 pmRNSHolding(s) in Company
10th Nov 20229:40 amRNSHolding(s) in Company
10th Nov 20227:00 amRNSDirectorate Change
1st Nov 20229:48 amRNSTotal Voting Rights
31st Oct 20223:23 pmRNSHolding(s) in Company
26th Oct 20227:00 amRNSQ3 Trading Update
18th Oct 20223:13 pmRNSHolding(s) in Company
3rd Oct 20229:39 amRNSTotal Voting Rights
29th Sep 202212:45 pmRNSDirector/PDMR Shareholding
29th Sep 202210:12 amRNSDirector/PDMR Shareholding
22nd Sep 202211:17 amRNSDirector/PDMR Shareholding
21st Sep 20224:58 pmRNSDirector/PDMR Shareholding
21st Sep 20223:48 pmRNSDirector/PDMR Shareholding
6th Sep 202212:52 pmRNSDirector Declaration
5th Sep 20224:14 pmRNSAdditional Listing
1st Sep 202212:39 pmRNSHolding(s) in Company
1st Sep 20229:15 amRNSBlock listing Interim Review

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.